Genscript Biotech (G51.STU) Q1 2026 Earnings

15MarConfirmed
Q1 2026
-0.2
-0.14
-0.08
-0.03

Details

Expected EPS
-0.026244899999999998
Actual EPS
-0.2012109
Surprise EPS
-0.17
Surprise Percent
+666.67%

Description

Genscript Biotech (G51.STU) has reported earnings of -0.2012109 per share for Q1 2026.

0 Comments

Share your thoughts